Search

Search Constraints

You searched for: Author/Creator Eriksson, Carl

Search Results

3. Clinical effectiveness of golimumab in Crohn's disease: an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG). (2nd November 2018)

4. Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG. (2nd November 2021)

7. Disease course of inflammatory bowel disease unclassified in a European population‐based inception cohort: An Epi‐IBD study. Issue 6 (21st January 2019)

8. Drug survival of anti‐TNF agents compared with vedolizumab as a second‐line biological treatment in inflammatory bowel disease: results from nationwide Swedish registers. Issue 4 (19th December 2020)

9. Editorial: infliximab or adalimumab as first‐ or second‐line anti‐TNF—conflicting evidence—authors' reply. Issue 6 (23rd August 2021)

10. Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study. (27th July 2022)